Healthcare -
Biotechnology - NASDAQ - US
$ 1.0094
-8.24 %
$ 2.07 M
Market Cap
0.04
P/E
ATXI - STOCK-BASED COMPENSATION
Stock-based Compensation ATXI - Avenue Therapeutics, Inc.
906 K
LAST VALUE
43.17%
2 YEAR CAGR
-10.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR